Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Bianca Posocco

9PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsCharacterisation of biological macromoleculesPharmaceutical delivery technologiesGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Apr 14, 2026
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients.

Bianca Posocco, Diletta Pasin, Nicoletta De Cesaro

|Oct 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring.

Eleonora Cecchin, Marco Orleni, Sara Gagno

|Feb 17, 2024
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.

Bianca Posocco, Martina Zanchetta, Marco Orleni

|Nov 13, 2023
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco

|Jun 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte

|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

Giovanni Canil, Marco Orleni, Bianca Posocco

Pageof 2

Frequent Collaborators

5 joint publications

Sara Gagno

5 joint publications

Giuseppe Toffoli

5 joint publications

Erika Cecchin

4 joint publications

Rossana Roncato

3 joint publications

Chiara Dalle Fratte

3 joint publications

Marco Orleni

3 joint publications

Fabio Puglisi

3 joint publications

Michela Guardascione

2 joint publications

Martina Zanchetta

2 joint publications

Angela Buonadonna

Frequent Collaborators

5 joint publications

Sara Gagno

5 joint publications

Giuseppe Toffoli

5 joint publications

Erika Cecchin

4 joint publications

Rossana Roncato

Top Related Videos

Serum and Plasma Copy Number Detection Using Real-time PCR
09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on : Dec 15, 2017

11.9K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on : Apr 07, 2023

1.9K
See more related videos

Top Related Videos

Serum and Plasma Copy Number Detection Using Real-time PCR
09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on : Dec 15, 2017

11.9K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on : Apr 07, 2023

1.9K
See more related videos